When Robots Sleep, Do They Dream of Algorithms?

September 20, 2019

Science Magazine

  • “As artificial intelligence becomes a standard laboratory tool, scientists are quickly discovering both the promise and perils of algorithmically driven research. Artificial intelligence (AI) is cropping up everywhere these days, according to major news sources that are themselves increasingly driven by computer algorithms. Machine learning algorithms running on neural networks are often called deep learning systems, to distinguish them from other approaches such as statistical correlation.”

 

  • The article delves into the concept of ‘sleep’ in robots and AI systems, exploring how these technologies use downtime to optimize their performance. When not actively engaged, AI algorithms can undergo processes akin to human dreaming, such as self-repair, data organization, and learning enhancement. This nocturnal activity allows robots to improve their algorithms, refine their functions, and adapt better to new tasks. The article highlights the importance of these processes for the advancement of AI, making machines more efficient and smarter in their operations.

 

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading